The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN Discovery Fellowship 2025, 2026Targeting Rubicon to Restore Lysosomal and Autophagic Health in LRRK2 Mediated Parkinson’s Disease
Study Rationale:
Parkinson’s disease develops in part because brain cells lose the ability to clear away damaged proteins and cell parts, leading to stress and cell death. A…
-
ASAP CRN Discovery Fellowship 2025, 2026Cryo-ET and Lipidomics of Lysosome Damage in Familial and Sporadic Parkinson’s Disease
Study Rationale:
Parkinson’s disease (PD) is driven by many factors, but a common feature is the buildup of a sticky protein called alpha-synuclein. These protein clumps can…
-
ASAP CRN Discovery Fellowship 2025, 2026How the Spatiotemporal Dynamics of Dopamine Transmission Shift in Parkinson’s Disease to Support Motor Function
Study Rationale:
Loss of dopamine in the brain is the main cause of Parkinson’s disease motor symptoms. Previous research shows that the brain can lose many of the cells that…
-
ASAP CRN Discovery Fellowship 2025, 2026Dynamic Regulatory Role of Transposable Elements Through Human Ageing and Parkinson’s Disease
Study Rationale:
Many people assume that most of our DNA is made up of genes, but in fact, genes account for only about 2% of the human genome. More than half is made up of…
-
ASAP CRN Discovery Fellowship 2025, 2026Recapitulating Subtype-Specific Cell-Autonomous Human Dopaminergic Vulnerability in Parkinson’s Disease
Study Rationale:
In Parkinson’s disease (PD), certain brain cells that make dopamine, called A9 neurons, slowly die. These cells are very active and have long, branching…
-
ASAP CRN Discovery Fellowship 2025, 2026Exploring How Mutations in the LRRK2 Gene Change mRNA and Protein Selection and How This Can Be Used for Diagnosis and Treatment of Parkinson’s Disease
Study Rationale:
Mutations in the LRRK2 gene are the most common inherited cause of Parkinson’s disease. These changes affect how cells read and process genetic messages, producing different versions…
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.